FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Serum symmetric dimethylarginine concentration in healthy ne...
Equine veterinary journal2021; 54(5); 958-964; doi: 10.1111/evj.13520

Serum symmetric dimethylarginine concentration in healthy neonatal Thoroughbred foals.

Abstract: Symmetric dimethylarginine (SDMA) is widely used in other species as a marker of renal dysfunction and is considered a more sensitive indicator of glomerular filtration rate than creatinine. Reference ranges are established in healthy adult horses (≤14 μg/dL) and concentrations are increased in horses with acute kidney injury (median 32 μg/dL; range 15-92). Objective: To establish the normal range of SDMA concentrations in neonatal Thoroughbreds. Methods: Cross-sectional. Methods: Blood samples were collected from Thoroughbred foals <36 h old deemed healthy by physical examination. Exclusion criteria included foals from mares undergoing treatment for placentitis and foals that developed clinical disease or died/euthanised <2 weeks from birth. Biochemistry and serum SDMA concentrations were obtained. Results: Subjects included 120 foals. Median age was 13.5 h (range 1.0-34.0). Median and 95% confidence interval for SDMA concentration was 69.0 µg/dL (63.0, 75.0; range 35.0-376.0). A cut-off value of 168 µg/dL would include 95% of individuals and is therefore suggested. Serum SDMA concentration was correlated with age (R = -.3, P = .003), creatinine concentration (R = .6, P ≤ .001) and urea concentration (R = .3, P = .002). Conclusions: Limitations include a small sample size, no consideration of subclinical disease and a short follow-up period. Conclusions: In equine neonates, SDMA concentration is higher than in adult horses, older foals and adults with acute kidney injury. Therefore, currently SDMA cannot be used as a marker of renal dysfunction in this age group. Further work is required to assess whether SDMA concentration is increased in neonates with renal disease and, if so, what cut-off should be used.
© 2021 EVJ Ltd.
Get Full Text
Publication Date: 2021-10-20 PubMed ID: 34606121DOI: 10.1111/evj.13520Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study aimed to determine the normal range of symmetric dimethylarginine (SDMA) concentrations in newborn Thoroughbred foals. The findings suggest that SDMA levels in neonate horses are higher than in adult horses, older foals, and adults with acute kidney injury, meaning SDMA can’t currently be used to indicate renal dysfunction in this age group.

Research Background

The research focused on symmetric dimethylarginine (SDMA), a biomarker that is generally used to denote renal dysfunction issues in various species. It is deemed as a more sensitive indicator of the glomerular filtration rate when compared to creatinine. In adult horses, reference ranges have been established for SDMA levels, with an increase noted in horses suffering from acute kidney injury.

Objective of the Study

The primary goal of the research was to establish the typical range of SDMA concentrations in newborn Thoroughbred horses called foals. The findings of this would add to the understanding and treatment of potential renal diseases in these horses.

Methodology and Findings

  • The study involved a cross-sectional methodology. Blood samples were drawn from Thoroughbred foals younger than 36 hours and visual examination deemed the animals healthy. Foals excluded from the study were ones born to mares undergoing treatment for placentitis or if the foals developed clinical disease or died/were euthanised within two weeks of birth.
  • A total of 120 foals were included in this study. Their median age was 13.5 hours. The median and 95% confidence interval for SDMA concentration was registered at 69.0 µg/dL.
  • The research suggests 168 µg/dL as the SDMA cut-off value. This would encompass 95% of individuals. They found SDMA concentration correlated with age, creatinine concentration, and urea concentration.

Conclusions and Limitations

  • The final conclusion drawn from the study indicates that SDMA concentration in equine neonates (young foals) is significantly higher than in adult horses, older foals, and even adult horses suffering from acute kidney injury. This suggests that at present, SDMA levels can’t be used as a renal dysfunction marker in newborn Thoroughbred foals.
  • However, the findings of the study remain limited due to a small sample size and lack of consideration for subclinical disease. Also, the follow-up period was relatively short.

Future Work

The researchers recommend further studies to identify whether SDMA concentration increases in neonates with kidney disease. If this is the case, determining what cut-off value should be used would also be essential.

Cite This Article

APA
Gough RL, McGovern KF. (2021). Serum symmetric dimethylarginine concentration in healthy neonatal Thoroughbred foals. Equine Vet J, 54(5), 958-964. https://doi.org/10.1111/evj.13520

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 54
Issue: 5
Pages: 958-964

Researcher Affiliations

Gough, Rachel L
  • Donnington Grove Veterinary Group, Newbury, UK.
McGovern, Kate F
  • Donnington Grove Veterinary Group, Newbury, UK.

MeSH Terms

  • Acute Kidney Injury / veterinary
  • Animals
  • Arginine / analogs & derivatives
  • Biomarkers
  • Creatinine
  • Cross-Sectional Studies
  • Female
  • Horse Diseases / diagnosis
  • Horses
  • Humans
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / veterinary

Grant Funding

  • Donnington Grove Veterinary Group

References

This article includes 37 references
  1. Schott H. Review of azotemia in foals. AAEP Proceedings 2011;57.
  2. Schott HC. Chronic renal failure in horses. Vet Clin North Am Equine Pract 2007;23(3):593-612.
    doi: 10.1016/j.cveq.2007.10.002google scholar: lookup
  3. Edwards D, Brownlow M, Hutchins D. Indices of renal function: values in eight normal foals from birth to 56 days. Aust Veterinary J 1990;67(6):251-4.
  4. Axon JE, Palmer JE. Clinical pathology of the foal. Vet Clin North Am Equine Pract 2008;24(2):357-85.
    doi: 10.1016/j.cveq.2008.03.005google scholar: lookup
  5. Chaney KP, Holcombe SJ, Schott HC, Barr BS. Spurious hypercreatininemia: 28 neonatal foals (2000-2008). J Vet Emerg Crit Care 2010;20(2):244-9.
    doi: 10.1111/j.1476-4431.2010.00525google scholar: lookup
  6. Guignard J-P, Drukker A. Why do newborn infants have a high plasma creatinine?. Pediatrics 1999;103(4):e49.
  7. Brewer BD, Clement SF, Stephen Lotz W, Gronwall R, Gimotty PA, Meyer J. Endogenous substances, and urinary diagnostic indices in healthy neonatal foals. J Vet Intern Med 1991;5(1):28-33.
  8. Rossier Y, Divers TJ, Sweeney RW. Variations in urinary gamma glutamyl transferase/urinary creatinine ratio in horses with or without pleuropneumonia treated with gentamicin. Equine Vet J 1995;27(3):217-20.
    doi: 10.1111/j.2042-3306.1995.tb03065google scholar: lookup
  9. Adams R, McClure JJ, Gossett KA, Koonce KL, Ezigbo C. Evaluation of a technique for measurement of gamma-glutamyltranspeptidase in equine urine. Am J Vet Res 1985;46(1):147-50.
  10. Frey K, Mondorf WA, Geiger H, Mondorf UF. Influence of diuresis on enzymuria. Ren Fail 2001;23(3-4):377-84.
    doi: 10.1081/jdi-100104721google scholar: lookup
  11. Waikar SS, Sabbisetti VS, Bonventre JV. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010;78(5):486-94.
    doi: 10.1038/ki.2010.165google scholar: lookup
  12. de Loor J, Daminet S, Smets P, Maddens B, Meyer E. Urinary biomarkers for acute kidney injury in dogs. J Vet Intern Med 2013;27(5):998-1010.
    doi: 10.1111/jvim.12155google scholar: lookup
  13. Fletcher JR, Bertin FR, Owen H, Fraser NS, Rose AM, Stewart AJ. Oxytetracycline associated acute kidney injury in a neonatal foal. Equine Vet Educ 2020;33(10):508.
    doi: 10.1111/eve.13372google scholar: lookup
  14. Hokamp JA, Nabity MB. Renal biomarkers in domestic species. Vet Clin Pathol 2016;45(1):28-56.
    doi: 10.1111/vcp.12333google scholar: lookup
  15. Relford R, Robertson J, Clements C. Symmetric dimethylarginine: improving the diagnosis and staging of chronic kidney disease in small animals. Vet Clin North Am Small Anim Pract 2016;46(6):941-60.
    doi: 10.1016/j.cvsm.2016.06.010google scholar: lookup
  16. Hall JA, Yerramilli M, Obare E, Yerramilli M, Almes K, Jewell DE. Serum concentrations of symmetric dimethylarginine and creatinine in dogs with naturally occurring chronic kidney disease. J Vet Intern Med 2016;30(3):794-802.
    doi: 10.1111/jvim.13942google scholar: lookup
  17. Hall JA, Yerramilli M, Obare E, Yerramilli M, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med 2014;28(6):1676-83.
  18. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - A meta-analysis. Nephrol Dial Transplant 2006;21(9):2446-51.
    doi: 10.1093/ndt/gfl292google scholar: lookup
  19. Schott HC, Gallant LR, Coyne M. Symmetric dimethylarginine and creatinine concentrations in serum of healthy draft horses. J Vet Intern Med 2021;35(2):1147-54.
    doi: 10.1111/jvim.16042google scholar: lookup
  20. Siwinska N, Zak A, Slowikowska M, Niedzwiedz A, Paslawska U. Serum symmetric dimethylarginine concentration in healthy horses and horses with acute kidney injury. BMC Vet Res 2020;16(1):396.
    doi: 10.1186/s12917-020-02621google scholar: lookup
  21. Bozorgmanesh R, Magdesian KG, Offer K. Equine neonatal symmetric dimethylarginine in sick neonates with hypercreatininemia. J Vet Emerg Crit Care 2019;29(S1):S30.
    doi: 10.1111/vec.12877google scholar: lookup
  22. Liffman R, Johnstone T, Tennent-Brown B, Hepworth G, Courtman N. Establishment of reference intervals for serum symmetric dimethylarginine in adult nonracing Greyhounds. Vet Clin Pathol 2018;47(3):458-63.
    doi: 10.1111/vcp.12638google scholar: lookup
  23. Nabity MB, Lees GE, Boggess MM. Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs. J Vet Intern Med 2015;29(4):1036-44.
    doi: 10.1111/jvim.12835google scholar: lookup
  24. Hall JA, Yerramilli M, Obare E, Yerramilli M, Melendez LD, Jewell DE. Relationship between lean body mass and serum renal biomarkers in healthy dogs. J Vet Intern Med 2015;29(3):808-14.
    doi: 10.1111/jvim.12607google scholar: lookup
  25. Toribio RE. Essentials of Equine Renal and Urinary Tract Physiology. Vet Clin North Am Equine Pract 2007;23(3):533-61.
    doi: 10.1016/j.cveq.2007.09.006google scholar: lookup
  26. Chucri TM, Monteiro JM, Lima AR, Salvadori MLB, Junior JRK, Miglino MA. A review of immune transfer by the placenta. J Reprod Immunol 2010;87(1-2):14-20.
    doi: 10.1016/j.jri.2010.08.062google scholar: lookup
  27. Schwedhelm E, Xanthakis V, Maas R. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort. Clin Chem Lab Med 2011;49(11):1907-10.
    doi: 10.1515/cclm.2011.679google scholar: lookup
  28. Protas PT, Tenderenda-Banasiuk E, Taranta-Janusz K, Fiłonowicz R, Zajac M, Wasilewska A. Is symmetric dimethylarginine a sensitive biomarker of subclinical kidney injury in children born with low birth weight?. Biomark J 2014;19(3):231-5.
    doi: 10.3109/1354750x.2014.899393google scholar: lookup
  29. Holdstock NB, Ousey JC, Rossdale PD. Glomerular filtration rate, effective renal plasma flow, blood pressure and pulse rate in the equine neonate during the first 10 days post partum. Equine Vet J 1998;30(4):335-43.
  30. Siroen MPC, van der Sijp JRM, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PAM. The human liver clears both asymmetric and symmetric dimethylarginine. Hepatol Commun 2005;41(3):559-65.
    doi: 10.1002/hep.20579google scholar: lookup
  31. Csapó-Kiss Z, Stefler J, Martin TG, Makray S, Csapó J. Composition of mares’ colostrum and milk. Protein content, amino acid composition and contents of macro- and micro-elements. Int Dairy J 1995;5:403-15.
  32. Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 2005;35(1):32-7.
    doi: 10.1111/j.1365-2362.2005.01445google scholar: lookup
  33. Fleck C, Schweitzer F, Karge E, Busch M, Stein G. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta 2003;336(1):1-12.
    doi: 10.1016/s0009-8981(03)00338-3google scholar: lookup
  34. Wilkins BH, Wilkins BH. Renal function in sick very low birthweight infants: 2. urea and creatinine excretion. Arch Dis Child 1992;67:1146-53.
  35. Senterre T, Rigo J. Blood urea nitrogen during the first 2 weeks of life in Vlbw infants receiving high protein intakes. Adv Pediatr Res 2011;70(5):767.
    doi: 10.1038/pr.2011.992google scholar: lookup
  36. Schepers E, Barreto D, Liabeuf S. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol 2011;6(10):2374-83.
    doi: 10.2215/cjn.01720211google scholar: lookup
  37. Friedrichs K, Harr K, Concordet D, Trumel C, Braun J. Reference values: a review. Vet Clin Pathol 2009;38(3):288-98.

Citations

This article has been cited 2 times.
  1. Galen GV, Olsen E, Siwinska N. Biomarkers of Kidney Disease in Horses: A Review of the Current Literature. Animals (Basel) 2022 Oct 5;12(19).
    doi: 10.3390/ani12192678pubmed: 36230418google scholar: lookup
  2. Camacho BE, Mitman SL, Foster DM, Halleran J. Validation of a reference interval for symmetric dimethylarginine in healthy goats and its comparison to values in goats with obstructive urolithiasis. J Vet Intern Med 2024 Sep-Oct;38(5):2807-2813.
    doi: 10.1111/jvim.17162pubmed: 39152724google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.